Method and composition for treating mammalian diseases caused by inflammatory response
AssigneeCellular Sciences, Inc.
InventorStanley E. Katz
Life of this patent
Estimating the term…
Abstract
A method for treating the disease state in mammals caused by mammalian cells involved in the inflammatory response is disclosed. Mammalian cells participating in the inflammatory response are contacted with an inflammatory response mediator which reduces the undesired inflammatory response and is an antioxidant. The inflammatory response mediator may further provide a cellular energy source and be a building block in the cellular synthesis of other cellular components. Compositions for reducing and treating undesired inflammatory response are also disclosed.
Claims9
A method for treating asthma in mammals caused by mammalian cells involved in the inflammatory response comprising:
- contacting the mammalian cells with an inflammatory mediator;
- wherein the inflammatory mediator is selected from the group consisting of pyruvate and a pyruvate precursor and is present in an amount capable of reducing the undesired inflammatory response and is an antioxidant provided that said pyruvate or pyruvate precursor is not administered together with albuterol.
Dependencies are inferred from the claim text.